Swift CC, Eklund MJ, Kraveka JM, Alazraki AL. Updates in diagnosis, management, and treatment of neuroblastoma. Radiographics. 2018;38:566–80.

Article  PubMed  Google Scholar 

Schmitt-Hoffner F, Van Rijn S, Toprak UH, Mauermann M, Rosemann F, Heit-Mondrzyk A, et al. FOXR2 stabilizes MYCN protein and identifies non-MYCN-amplified neuroblastoma patients with unfavorable outcome. J Clin Oncol. 2021;39:3217–28.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Otte J, Dyberg C, Pepich A, Johnsen JI. MYCN function in neuroblastoma development. Front Oncol. 2020;10:624079.

Article  PubMed  Google Scholar 

Pinto NR, Applebaum MA, Volchenboum SL, Matthay KK, London WB, Ambros PF, et al. Advances in risk classification and treatment strategies for neuroblastoma. J Clin Oncol. 2015;33:3008–17.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fletcher JI, Ziegler DS, Trahair TN, Marshall GM, Haber M, Norris MD. Too many targets, not enough patients: rethinking neuroblastoma clinical trials. Nat Rev Cancer. 2018;18:389–400.

Article  CAS  PubMed  Google Scholar 

Wolpaw AJ, Bayliss R, Büchel G, Dang CV, Eilers M, Gustafson WC, et al. Drugging the “Undruggable” MYCN oncogenic transcription factor: overcoming previous obstacles to impact childhood cancers. Cancer Res. 2021;81:1627–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Otto T, Horn S, Brockmann M, Eilers U, Schüttrumpf L, Popov N, et al. Stabilization of N-Myc is a critical function of Aurora a in human neuroblastoma. Cancer Cell. 2009;15:67–78.

Article  CAS  PubMed  Google Scholar 

Gustafson WC, Meyerowitz JG, Nekritz EA, Chen J, Benes C, Charron E, et al. Drugging MYCN through an allosteric transition in Aurora kinase a. Cancer Cell. 2014;26:414–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Puissant A, Frumm SM, Alexe G, Bassil CF, Qi J, Chanthery YH, et al. Targeting MYCN in neuroblastoma by BET bromodomain inhibition. Cancer Discov. 2013;3:308–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rohaan MW, Gomez-Eerland R, Van Den Berg JH, Geukes Foppen MH, Van Zon M, Raud B, et al. MART-1 TCR gene-modified peripheral blood T cells for the treatment of metastatic melanoma: a phase I/IIa clinical trial. Immunooncol Technol. 2022;15:100089.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Toyoshima M, Howie HL, Imakura M, Walsh RM, Annis JE, Chang AN, et al. Functional genomics identifies therapeutic targets for MYC-driven cancer. Proc Natl Acad Sci USA. 2012;109:9545–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Czerwińska P, Mazurek S, Wiznerowicz M. The complexity of TRIM28 contribution to cancer. J Biomed Sci. 2017;24:63.

Article  PubMed  PubMed Central  Google Scholar 

Huang N, Sun X, Li P, Liu X, Zhang X, Chen Q, et al. TRIM family contribute to tumorigenesis, cancer development, and drug resistance. Exp Hematol Oncol. 2022;11:75.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pineda CT, Ramanathan S, Fon Tacer K, Weon JL, Potts MB, Ou YH, et al. Degradation of AMPK by a cancer-specific ubiquitin ligase. Cell. 2015;160:715–28.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang C, Ivanov A, Chen L, Fredericks WJ, Seto E, Rauscher FJ 3rd, et al. MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation. EMBO J. 2005;24:3279–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma X, Yang T, Luo Y, Wu L, Jiang Y, Song Z, et al. TRIM28 promotes HIV-1 latency by SUMOylating CDK9 and inhibiting P-TEFb. Elife. 2019;8:e42426.

Article  PubMed  PubMed Central  Google Scholar 

Li M, Xu X, Chang CW, Liu Y. TRIM28 functions as the SUMO E3 ligase for PCNA in prevention of transcription induced DNA breaks. Proc Natl Acad Sci USA. 2020;117:23588–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Diao Z, Ji Q, Wu Z, Zhang W, Cai Y, Wang Z, et al. SIRT3 consolidates heterochromatin and counteracts senescence. Nucleic Acids Res. 2021;49:4203–19.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rowe HM, Jakobsson J, Mesnard D, Rougemont J, Reynard S, Aktas T, et al. KAP1 controls endogenous retroviruses in embryonic stem cells. Nature. 2010;463:237–40.

Article  CAS  PubMed  Google Scholar 

Ecco G, Cassano M, Kauzlaric A, Duc J, Coluccio A, Offner S, et al. Transposable elements and their KRAB-ZFP controllers regulate gene expression in adult tissues. Dev Cell. 2016;36:611–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bacon CW, Challa A, Hyder U, Shukla A, Borkar AN, Bayo J, et al. KAP1 is a chromatin reader that couples steps of RNA polymerase II transcription to sustain oncogenic programs. Mol Cell. 2020;78:1133–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mcnamara RP, Reeder JE, Mcmillan EA, Bacon CW, Mccann JL, D’orso I. KAP1 recruitment of the 7SK snRNP complex to promoters enables transcription elongation by RNA polymerase II. Mol Cell. 2016;61:39–53.

Article  CAS  PubMed  Google Scholar 

Xu W, Li J, He C, Wen J, Ma H, Rong B, et al. METTL3 regulates heterochromatin in mouse embryonic stem cells. Nature. 2021;591:317–21.

Article  CAS  PubMed  Google Scholar 

Percharde M, Lin CJ, Yin Y, Guan J, Peixoto GA, Bulut-Karslioglu A, et al. A LINE1-Nucleolin partnership regulates early development and ESC identity. Cell. 2018;174:391–405.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sang Y, Li Y, Song L, Alvarez AA, Zhang W, Lv D, et al. TRIM59 promotes Gliomagenesis by inhibiting TC45 Dephosphorylation of STAT3. Cancer Res. 2018;78:1792–804.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Song L, Yu B, Yang Y, Liang J, Zhang Y, Ding L, et al. Identification of functional cooperative mutations of GNAO1 in human acute lymphoblastic leukemia. Blood. 2021;137:1181–91.

Article  CAS  PubMed  Google Scholar 

Yang Y, Wang S, Cai J, Liang J, Zhang Y, Xie Y, et al. Targeting ARHGEF12 promotes neuroblastoma differentiation, MYCN degradation, and reduces tumorigenicity. Cell Oncol (Dordr). 2023;46:133–43.

Article  CAS  PubMed  Google Scholar 

Ghosh S, Jacobson A. RNA decay modulates gene expression and controls its fidelity. Wiley Interdiscip Rev RNA. 2010;1:351–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boo SH, Kim YK. The emerging role of RNA modifications in the regulation of mRNA stability. Exp Mol Med. 2020;52:400–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Z, Theler D, Kaminska KH, Hiller M, De La Grange P, Pudimat R, et al. The YTH domain is a novel RNA binding domain. J Biol Chem. 2010;285:14701–10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu C, Wang X, Liu K, Roundtree IA, Tempel W, Li Y, et al. Structural basis for selective binding of m6A RNA by the YTHDC1 YTH domain. Nat Chem Biol. 2014;10:927–9.

Article  CAS  PubMed  Google Scholar 

Li F, Yi Y, Miao Y, Long W, Long T, Chen S, et al. N(6)-Methyladenosine modulates nonsense-mediated mRNA decay in human glioblastoma. Cancer Res. 2019;79:5785–98.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu S, Li G, Li Q, Zhang Q, Zhuo L, Chen X, et al. The roles and mechanisms of YTH domain-containing proteins in cancer development and progression. Am J Cancer Res. 2020;10:1068–84.

PubMed  PubMed Central  Google Scholar 

Fong KW, Zhao JC, Song B, Zheng B, Yu J. TRIM28 protects TRIM24 from SPOP-mediated degradation and promotes prostate cancer progression. Nat Commun. 2018;9:5007.

Article  PubMed  PubMed Central